Clinical Trial Update: BV-CHP Real-life and Biological Evidences in Patients With sALCL

View source ↗

Summary

This trial update from Fondazione Italiana Linfomi- ETS describes real-life and biological evidence regarding the BV-CHP regimen (brentuximab vedotin with cyclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Anaplastic Large Cell Lymphoma | Status: NOT_YET_RECRUITING